Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

Pacific Hybreed Secures $1M to Scale Shellfish Genetics and Hatchery Operations

Scale gets decided early in aquaculture, long before product hits a plate, and Pacific Hybreed is building right at that inflection point where biology either delivers or disappoints. Out of Kailua-Kona and Honolulu, Pacific Hybreed just secured $1M, with Hawaiʻi Angels and Blue Startups stepping in behind the curtain, not to fund noise but to fund nuance, because in aquaculture the real leverage is not downstream, it is in the seed, quiet work, technical work, the kind that either compounds or collapses.

Melissa Dellatorre, CEO, is driving this with a clear eye on scale that actually holds, while Francis Pan, CSO, is deep in the genetics where performance is engineered, not hoped for, and behind that the original signal still echoes through Joth Davis and Dennis Hedgecock, co-founders who turned shellfish genetics into something commercially real, not just academically admired.

This is not innovation theater, this is hybrid vigor, selective breeding, and years of scientific discipline showing up to do a job most markets ignore until it becomes a problem, oyster, clam, call it what it is, biological infrastructure, because if the inputs fail everything downstream feels it.

The earlier $800K round in 2022 was about proving the engine could run under pressure, capacity went up, breeding programs got sharper, and this new capital is about letting that engine breathe, expanding hatchery operations, increasing production, extending the model beyond oysters into clams without losing the genetic edge that makes it all work.

And while everyone loves to talk about disruption, this is what it actually looks like in the wild, not loud, not overnight, just a team that understands where the real constraint lives and decides to own it.

You see it in the broader bench too, Megan Fellstrom and Will Hadley working the research layer, Samuel Tuhy, Gillian Douglas, and Cole Sharbonow handling the technical backbone that turns theory into throughput, no headlines for that part, but without it none of this scales.

The market rewards outcomes, but outcomes are built upstream, the closer you get to the origin of a problem, the more control you have over everything that follows, and Pacific Hybreed is not chasing the tide, they are engineering what grows in it.